- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.41 Å
- Oligo State
- homo-16-mer
- Ligands
- 16 x MSE- PHE- ASN- PHE- LEU- GLY: CED-3 fragment(Non-covalent)
- 16 x MG: MAGNESIUM ION(Non-covalent)
MG.5: 5 residues within 4Å:- Chain A: S.166, D.250, D.251, T.271
- Ligands: ATP.6
2 PLIP interactions:2 interactions with chain A- Metal complexes: A:S.166, A:D.250
MG.7: 3 residues within 4Å:- Chain B: S.166, D.250
- Ligands: ATP.8
1 PLIP interactions:1 interactions with chain B- Metal complexes: B:S.166
MG.9: 4 residues within 4Å:- Chain C: S.166, K.191, D.250
- Ligands: ATP.10
1 PLIP interactions:1 interactions with chain C- Metal complexes: C:S.166
MG.11: 6 residues within 4Å:- Chain D: K.165, S.166, D.250, D.251, T.271
- Ligands: ATP.12
2 PLIP interactions:2 interactions with chain D- Metal complexes: D:S.166, D:D.250
MG.17: 5 residues within 4Å:- Chain E: S.166, D.250, D.251, T.271
- Ligands: ATP.18
2 PLIP interactions:2 interactions with chain E- Metal complexes: E:S.166, E:D.250
MG.19: 3 residues within 4Å:- Chain F: S.166, D.250
- Ligands: ATP.20
1 PLIP interactions:1 interactions with chain F- Metal complexes: F:S.166
MG.21: 4 residues within 4Å:- Chain G: S.166, K.191, D.250
- Ligands: ATP.22
1 PLIP interactions:1 interactions with chain G- Metal complexes: G:S.166
MG.23: 6 residues within 4Å:- Chain H: K.165, S.166, D.250, D.251, T.271
- Ligands: ATP.24
2 PLIP interactions:2 interactions with chain H- Metal complexes: H:S.166, H:D.250
MG.29: 5 residues within 4Å:- Chain I: S.166, D.250, D.251, T.271
- Ligands: ATP.30
2 PLIP interactions:2 interactions with chain I- Metal complexes: I:S.166, I:D.250
MG.31: 3 residues within 4Å:- Chain J: S.166, D.250
- Ligands: ATP.32
1 PLIP interactions:1 interactions with chain J- Metal complexes: J:S.166
MG.33: 4 residues within 4Å:- Chain K: S.166, K.191, D.250
- Ligands: ATP.34
1 PLIP interactions:1 interactions with chain K- Metal complexes: K:S.166
MG.35: 6 residues within 4Å:- Chain L: K.165, S.166, D.250, D.251, T.271
- Ligands: ATP.36
2 PLIP interactions:2 interactions with chain L- Metal complexes: L:S.166, L:D.250
MG.41: 5 residues within 4Å:- Chain M: S.166, D.250, D.251, T.271
- Ligands: ATP.42
2 PLIP interactions:2 interactions with chain M- Metal complexes: M:S.166, M:D.250
MG.43: 3 residues within 4Å:- Chain N: S.166, D.250
- Ligands: ATP.44
1 PLIP interactions:1 interactions with chain N- Metal complexes: N:S.166
MG.45: 4 residues within 4Å:- Chain O: S.166, K.191, D.250
- Ligands: ATP.46
1 PLIP interactions:1 interactions with chain O- Metal complexes: O:S.166
MG.47: 6 residues within 4Å:- Chain P: K.165, S.166, D.250, D.251, T.271
- Ligands: ATP.48
2 PLIP interactions:2 interactions with chain P- Metal complexes: P:S.166, P:D.250
- 16 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
ATP.6: 20 residues within 4Å:- Chain A: M.128, Y.131, A.161, G.162, S.163, G.164, K.165, S.166, V.167, Q.171, R.273, F.301, Y.305, P.330, A.331, M.334, T.367, P.368, Y.369
- Ligands: MG.5
12 PLIP interactions:12 interactions with chain A- Hydrogen bonds: A:Y.131, A:G.162, A:G.164, A:K.165, A:S.166, A:V.167, A:Y.305, A:Y.369
- Salt bridges: A:K.165, A:K.165, A:R.273
- pi-Stacking: A:F.301
ATP.8: 18 residues within 4Å:- Chain B: M.128, Y.131, A.161, G.162, G.164, K.165, S.166, V.167, R.273, F.301, Y.305, P.330, A.331, M.334, T.367, P.368, Y.369
- Ligands: MG.7
12 PLIP interactions:12 interactions with chain B- Hydrogen bonds: B:Y.131, B:G.162, B:G.164, B:K.165, B:S.166, B:V.167, B:Y.305, B:Y.369
- Salt bridges: B:K.165, B:K.165, B:R.273
- pi-Stacking: B:F.301
ATP.10: 20 residues within 4Å:- Chain C: M.128, Y.131, A.161, G.162, S.163, G.164, K.165, S.166, V.167, Q.171, R.273, F.301, Y.305, P.330, A.331, M.334, T.367, P.368, Y.369
- Ligands: MG.9
13 PLIP interactions:13 interactions with chain C- Hydrogen bonds: C:Y.131, C:G.162, C:G.164, C:K.165, C:S.166, C:V.167, C:Q.171, C:Y.369, C:Y.369
- Salt bridges: C:K.165, C:K.165, C:R.273
- pi-Stacking: C:F.301
ATP.12: 18 residues within 4Å:- Chain D: M.128, Y.131, A.161, G.162, G.164, K.165, S.166, V.167, Q.171, R.273, F.301, P.330, A.331, M.334, T.367, P.368, Y.369
- Ligands: MG.11
13 PLIP interactions:13 interactions with chain D- Hydrogen bonds: D:Y.131, D:G.162, D:G.164, D:K.165, D:S.166, D:V.167, D:Q.171, D:Y.369, D:Y.369
- Salt bridges: D:K.165, D:K.165, D:R.273
- pi-Stacking: D:F.301
ATP.18: 20 residues within 4Å:- Chain E: M.128, Y.131, A.161, G.162, S.163, G.164, K.165, S.166, V.167, Q.171, R.273, F.301, Y.305, P.330, A.331, M.334, T.367, P.368, Y.369
- Ligands: MG.17
12 PLIP interactions:12 interactions with chain E- Hydrogen bonds: E:Y.131, E:G.162, E:G.164, E:K.165, E:S.166, E:V.167, E:Y.305, E:Y.369
- Salt bridges: E:K.165, E:K.165, E:R.273
- pi-Stacking: E:F.301
ATP.20: 18 residues within 4Å:- Chain F: M.128, Y.131, A.161, G.162, G.164, K.165, S.166, V.167, R.273, F.301, Y.305, P.330, A.331, M.334, T.367, P.368, Y.369
- Ligands: MG.19
12 PLIP interactions:12 interactions with chain F- Hydrogen bonds: F:Y.131, F:G.162, F:G.164, F:K.165, F:S.166, F:V.167, F:Y.305, F:Y.369
- Salt bridges: F:K.165, F:K.165, F:R.273
- pi-Stacking: F:F.301
ATP.22: 20 residues within 4Å:- Chain G: M.128, Y.131, A.161, G.162, S.163, G.164, K.165, S.166, V.167, Q.171, R.273, F.301, Y.305, P.330, A.331, M.334, T.367, P.368, Y.369
- Ligands: MG.21
13 PLIP interactions:13 interactions with chain G- Hydrogen bonds: G:Y.131, G:G.162, G:G.164, G:K.165, G:S.166, G:V.167, G:Q.171, G:Y.369, G:Y.369
- Salt bridges: G:K.165, G:K.165, G:R.273
- pi-Stacking: G:F.301
ATP.24: 18 residues within 4Å:- Chain H: M.128, Y.131, A.161, G.162, G.164, K.165, S.166, V.167, Q.171, R.273, F.301, P.330, A.331, M.334, T.367, P.368, Y.369
- Ligands: MG.23
13 PLIP interactions:13 interactions with chain H- Hydrogen bonds: H:Y.131, H:G.162, H:G.164, H:K.165, H:S.166, H:V.167, H:Q.171, H:Y.369, H:Y.369
- Salt bridges: H:K.165, H:K.165, H:R.273
- pi-Stacking: H:F.301
ATP.30: 20 residues within 4Å:- Chain I: M.128, Y.131, A.161, G.162, S.163, G.164, K.165, S.166, V.167, Q.171, R.273, F.301, Y.305, P.330, A.331, M.334, T.367, P.368, Y.369
- Ligands: MG.29
12 PLIP interactions:12 interactions with chain I- Hydrogen bonds: I:Y.131, I:G.162, I:G.164, I:K.165, I:S.166, I:V.167, I:Y.305, I:Y.369
- Salt bridges: I:K.165, I:K.165, I:R.273
- pi-Stacking: I:F.301
ATP.32: 18 residues within 4Å:- Chain J: M.128, Y.131, A.161, G.162, G.164, K.165, S.166, V.167, R.273, F.301, Y.305, P.330, A.331, M.334, T.367, P.368, Y.369
- Ligands: MG.31
12 PLIP interactions:12 interactions with chain J- Hydrogen bonds: J:Y.131, J:G.162, J:G.164, J:K.165, J:S.166, J:V.167, J:Y.305, J:Y.369
- Salt bridges: J:K.165, J:K.165, J:R.273
- pi-Stacking: J:F.301
ATP.34: 20 residues within 4Å:- Chain K: M.128, Y.131, A.161, G.162, S.163, G.164, K.165, S.166, V.167, Q.171, R.273, F.301, Y.305, P.330, A.331, M.334, T.367, P.368, Y.369
- Ligands: MG.33
13 PLIP interactions:13 interactions with chain K- Hydrogen bonds: K:Y.131, K:G.162, K:G.164, K:K.165, K:S.166, K:V.167, K:Q.171, K:Y.369, K:Y.369
- Salt bridges: K:K.165, K:K.165, K:R.273
- pi-Stacking: K:F.301
ATP.36: 18 residues within 4Å:- Chain L: M.128, Y.131, A.161, G.162, G.164, K.165, S.166, V.167, Q.171, R.273, F.301, P.330, A.331, M.334, T.367, P.368, Y.369
- Ligands: MG.35
13 PLIP interactions:13 interactions with chain L- Hydrogen bonds: L:Y.131, L:G.162, L:G.164, L:K.165, L:S.166, L:V.167, L:Q.171, L:Y.369, L:Y.369
- Salt bridges: L:K.165, L:K.165, L:R.273
- pi-Stacking: L:F.301
ATP.42: 20 residues within 4Å:- Chain M: M.128, Y.131, A.161, G.162, S.163, G.164, K.165, S.166, V.167, Q.171, R.273, F.301, Y.305, P.330, A.331, M.334, T.367, P.368, Y.369
- Ligands: MG.41
12 PLIP interactions:12 interactions with chain M- Hydrogen bonds: M:Y.131, M:G.162, M:G.164, M:K.165, M:S.166, M:V.167, M:Y.305, M:Y.369
- Salt bridges: M:K.165, M:K.165, M:R.273
- pi-Stacking: M:F.301
ATP.44: 18 residues within 4Å:- Chain N: M.128, Y.131, A.161, G.162, G.164, K.165, S.166, V.167, R.273, F.301, Y.305, P.330, A.331, M.334, T.367, P.368, Y.369
- Ligands: MG.43
12 PLIP interactions:12 interactions with chain N- Hydrogen bonds: N:Y.131, N:G.162, N:G.164, N:K.165, N:S.166, N:V.167, N:Y.305, N:Y.369
- Salt bridges: N:K.165, N:K.165, N:R.273
- pi-Stacking: N:F.301
ATP.46: 20 residues within 4Å:- Chain O: M.128, Y.131, A.161, G.162, S.163, G.164, K.165, S.166, V.167, Q.171, R.273, F.301, Y.305, P.330, A.331, M.334, T.367, P.368, Y.369
- Ligands: MG.45
13 PLIP interactions:13 interactions with chain O- Hydrogen bonds: O:Y.131, O:G.162, O:G.164, O:K.165, O:S.166, O:V.167, O:Q.171, O:Y.369, O:Y.369
- Salt bridges: O:K.165, O:K.165, O:R.273
- pi-Stacking: O:F.301
ATP.48: 18 residues within 4Å:- Chain P: M.128, Y.131, A.161, G.162, G.164, K.165, S.166, V.167, Q.171, R.273, F.301, P.330, A.331, M.334, T.367, P.368, Y.369
- Ligands: MG.47
13 PLIP interactions:13 interactions with chain P- Hydrogen bonds: P:Y.131, P:G.162, P:G.164, P:K.165, P:S.166, P:V.167, P:Q.171, P:Y.369, P:Y.369
- Salt bridges: P:K.165, P:K.165, P:R.273
- pi-Stacking: P:F.301
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Huang, W. et al., Mechanistic insights into CED-4-mediated activation of CED-3. Genes Dev. (2013)
- Release Date
- 2013-10-23
- Peptides
- Cell death protein 4: ABCDEFGHIJKLMNOP
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
AF
BG
CH
DI
AJ
BK
CL
DM
AN
BO
CP
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.41 Å
- Oligo State
- homo-16-mer
- Ligands
- 16 x MSE- PHE- ASN- PHE- LEU- GLY: CED-3 fragment(Non-covalent)
- 16 x MG: MAGNESIUM ION(Non-covalent)
- 16 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Huang, W. et al., Mechanistic insights into CED-4-mediated activation of CED-3. Genes Dev. (2013)
- Release Date
- 2013-10-23
- Peptides
- Cell death protein 4: ABCDEFGHIJKLMNOP
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
AF
BG
CH
DI
AJ
BK
CL
DM
AN
BO
CP
D